<DOC>
	<DOCNO>NCT02436239</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety tolerability vilazodone treatment MDD pediatric outpatient ( 7-17 year ) .</brief_summary>
	<brief_title>A Study Vilazodone Pediatric Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Male Female outpatient betw een 717 year age Primary diagnosis major depressive disorder ( MDD ) Children 's Depression Rating ScaleRevised ( CDRSR ) score 40 great Clinical Global ImpressionsSeverity ( CGIS ) score 4 great Current ( past 3 month ) principal Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision base diagnosis Axis I disorder MDD primary focus treatment ( de novo patient ) History suicidal behavior , require precaution suicide Not generally healthy medical condition Seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>